Mental Health

Research groups

Eduard Vieta
Josefina Castro-Fornieles
Josep M Haro
Josep Lluis Conde-Sala, Feliciano Villar
Antonio Andres-Pueyo, Alberto Maydeu-Olivares, Noemí Pereda, Santiago Redondo Illescas, Alvaro Rodriguez-Carballeira
M. Teresa Anguera, Roser Bono, Juana Gomez-Benito, Georgina Guilera
Miquel Bernardo

Representative of the research area

Dr. Georgina Guilera Ferre

gguilera (at) ub.edu

Research in this area focuses on advancing mental health knowledge around underlying neurobiological mechanisms, cognitive and daily life functioning. It also focuses on developing new treatments and therapies for psychotic and affective disorders in childhood, adolescence, and adulthood.

 

Psychotic and affective disorders are among the most disabling mental disorders in the world. Depression, schizophrenia and bipolar disorder have a substantial economic impact in mental health and social services. They are a major contributor to increasing direct healthcare system costs (e.g., hospital inpatient stays, prescription drugs), direct social system costs (e.g., pensions, guardianship) and indirect costs (e.g., loss of productivity from unemployment, reduced work productivity among family caregiver). Recently, there has been a paradigm shift in the way we understand mental disorders, moving from pursuing a clinical remission (i.e., symptom-free periods) to a full recovery (i.e., good performance in everyday life). Under a multidisciplinary approach, the Institute actively embraces the challenge of advancing mental health knowledge around underlying neurobiological mechanisms, cognitive and daily life functioning, and new treatments and therapies in psychotic and affective disorders in childhood, adolescence, and adulthood.

Featured projects

 

  • Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative. European Union. 754907-1. Eduard Vieta
  • Clinical, cognitive and neuroimaging characteristics of child and adolescent offspring of patients diagnosed with schizophrenia and ADHD. Instituto de Salud Carlos III. Ministerio de Economia y Competitividad. PI18/00696. Josefina Castro-Fornieles
  • RESPOND_Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic. European Commission. 101016127. Josep Maria Haro Abad.
  • Trayectorias asociadas al género en la exclusión de las relaciones sociales en la vejez y sus consecuencias para la salud y bienestar: una perspectiva de ciclo vital. Ministerio de Ciencia, Innovación y Universidades. PCI2019-103627. Feliciano Villar
  • Schools Against Victimisation from an Early age. Education, Audiovisual and Culture Executive Agency (EACEA). 2018-1-ES01-KA201-050287. Noemi Pereda
  • Toward recovery in people diagnosed with a severe mental disorder: Definition, assessment and intervention (RECO-DAI). Ministerio de Innovación, Ciencia y Universidades. PID2019-109887GB-I00. Juana Gomez-Benito i Georgina Guilera
  • Biomarkers of synaptic loss, neuronal damage and inflammation in cerebrospinal fluid (CSF) and peripheral blood in patients with a first psychotic episode. Instituto de Salud Carlos III. Ministerio de Economía y competitividad. PI20/01006. Miquel Bioque i Miquel Bernardo
  • Network Center for Biomedical Research in Mental Health (CIBERSAM)